Metastatic Breast Cancer Treatment Planning

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Metastatic Breast Cancer
Interventions
OTHER

Carevive CPS

This intervention will focus on the use of the Carevive CPS at the point of treatment decision making, enabling providers to deliver evidence-based and personalized treatment care plans to their metastatic breast cancer patients on active treatment. The Carevive CPS collects electronic patient reported outcomes (ePROs) and clinical data, reported and generated by clinical staff and/or peer-reviewed evidence, and includes patient education, resources, and referrals developed by cancer clinicians and researchers.

Sponsors
All Listed Sponsors
lead

Carevive Systems, Inc.

INDUSTRY

NCT03127332 - Metastatic Breast Cancer Treatment Planning | Biotech Hunter | Biotech Hunter